Literature DB >> 10788599

Consideration of cytokines as therapeutics agents or targets.

Z Xing1, J Wang.   

Abstract

There has been an explosion of our knowledge in cytokine biology in the last decade. Such knowledge is being quickly translated into the identification of etiologies and improved prophylaxis and therapy of disease. While cytokines have the potential to be used as therapeutics or immune adjuvants for certain diseases, they may also be culprits as therapeutic targets in other diseases. This review article serves, as an introduction to the other five articles in this thematic issue each of which has a specific focus on the frontier of cytokine therapeutic biology. This review contains sections dealing with general cytokine properties, cytokine classifications, human conditions caused by cytokine under-expression and over-expression, Th1 and Th2 paradigm, cytokine therapy for acute/chronic inflammatory conditions, cytokine therapy for infectious diseases, and cytokine therapy for cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788599     DOI: 10.2174/1381612003400623

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  Kampo medicine "Dai-kenchu-to" prevents CPT-11-induced small-intestinal injury in rats.

Authors:  Motoya Chikakiyo; Mitsuo Shimada; Toshihiro Nakao; Jun Higashijima; Kozo Yoshikawa; Masanori Nishioka; Takashi Iwata; Nobuhiro Kurita
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

Review 2.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

3.  Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation.

Authors:  Kavitha Viswanathan; Firdaus S Dhabhar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-07       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.